WHOOP Receives FDA Warning Letter Over Blood Pressure Claims; Class Action Lawsuit Filed

·

·

📊 Industry Moves

WHOOP’s getting hit with an FDA warning for marketing blood pressure insights without clinical validation—a reminder that fitness-wearable brands can’t legally claim to measure specific health metrics unless they’ve actually proven it.

Marty’s Take:

The FDA has been telegraphing this crackdown for years — WHOOP just drew the short straw. Every major wearable brand is now quietly auditing its health feature language, because blood pressure monitoring is a 2026 selling point but marketing it as medical-grade without clearance is a liability. Before buying, check whether features are actually FDA-cleared rather than just advertised — our best fitness tracker guide breaks down what’s verified.

Source: MobiHealthNews